January 2010 - Volume 21 - Issue 1
pp: 1-130

Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell...

Némati, Fariba; Daniel, Catherine; Arvelo, Francisco; More

Anti-Cancer Drugs . 21(1):25-32, January 2010.


Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy

Saji, Hisashi; Tsuboi, Masahiro; Matsubayashi, Jun; More

Anti-Cancer Drugs . 21(1):89-93, January 2010.

Erlotinib 150 mg daily plus chemotherapy in advanced pancreatic cancer: an interim safety analysis of a multicenter, randomized, cross-over phase III trial of the...

Boeck, Stefan; Vehling-Kaiser, Ursula; Waldschmidt, Dirk; More

Anti-Cancer Drugs . 21(1):94-100, January 2010.

Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial

Perdonà, Sisto; Di Lorenzo, Giuseppe; Cantiello, Francesco; More

Anti-Cancer Drugs . 21(1):101-106, January 2010.

Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer

Kim, Hyo Song; Yi, Seong Yoon; Jun, Hyun Jung; More

Anti-Cancer Drugs . 21(1):107-112, January 2010.

Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution

Fayette, Jérôme; Boyle, Helen; Chabaud, Sylvie; More

Anti-Cancer Drugs . 21(1):113-119, January 2010.